期刊文献+

临床试验对心房颤动节律和频率控制的评价 被引量:1

暂未订购
导出
摘要 有研究表明,心房颤动是死亡的独立危险因素,本文总结临床试验对心房颤动行节律控制或频率控制治疗的评价,结果表明,节律控制的优势未获证实,而频率控制方法简便易行,其效果至少与节律控制相同,应将频率控制作为心房颤动一线干预对策,对持续性心房颤动着重于复律治疗的方案应作调整。
作者 郑刚 张承宗
出处 《国外医学(内科学分册)》 2003年第6期231-234,共4页 Foreign Medical Sciences(Section of Internal Medicine)
  • 相关文献

参考文献1

共引文献95

同被引文献12

  • 1Hohnloser SH, Kuek KH, Lilienthal J. Rhythm or rate control in atrial fibrillation--Pharmacological Intervention in Atrial Fibrillation (PIAF) : a randomised trial. Lancet,2000,356 : 1789-1794.
  • 2Carlsson J,Miketic S, Windeler J, et al. Randomized trial of ratecontrol versus rhythm-control in persistent atrial fibrillation: the Strategies of Treatment of Atrial Fibrillation (STAF) study. J Am Coll Cardiol, 2003, 41:1690-1696.
  • 3Wyse DG, Waldo AL, DiMarco JP, et al. A comparison of rate control and rhythm control in patients with atrial fibrillation. N Engl J Med,2002,347 : 1825-1833.
  • 4Van Gelder IC, Hagens VE, Bosker HA, et al. A comparison of rate control and rhythm control in patients with recurrent persistent atrial fibrillation. N Engl J Med ,2002,347 : 1834-1840.
  • 5Chung MK, Shemanski L, Sherman DG, et al. Functional status in rate- versus rhythm-control strategies for atrial fibrillation: results of the Atrial Fibrillation Follow-Up Investigation of Rhythm Management (AFFIRM) Functional Status Substudy. J Am Coll Cardiol,2005,46 : 1891-1899.
  • 6Freudenberger RS, Wilson AC, Kostis JB. Comparison of rate versus rhythm control for atrial fibrillation in patients with left ventricular dysfunction (from the AFFIRM Study). Am J Cardiol, 2007,100:247-252.
  • 7Roy D, Talajic M, Nattel S, et al. Rhythm control versus rate control for atrial fibrillation and heart failure. N Engl J Med,2008,358: 2667 -2677.
  • 8Crijns HJ. Rate versus rhythm control in patients with atrial fibrillation: what the trials really say. Drugs, 2005,65: 1651- 1667.
  • 9Singh BN, Connolly SJ, Crijns HJ, et al. Dronedarone for maintenance of sinus rhythm in atrial fibrillation or flutter. N Engl J Med ,2007,357:987-999.
  • 10Hohnloser SH, Connolly SJ, Crijns HJ, et al. Rationale and design of ATHENA: A placebo-controlled, double-blind, parallel arm Trial to assess the efficacy of dronedarone 400 mg bid for the prevention of cardiovascular Hospitalization or death from any cause in patiENts with Atrial fibrillation/atrial flutter. J Cardiovasc Electrophysiol, 2008,19:69-73.

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部